ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,062,970 | -26.0% | 411,722 | -1.8% | 0.01% | -20.0% |
| Q2 2023 | $14,943,750 | +32.5% | 419,062 | -5.6% | 0.01% | +25.0% |
| Q1 2023 | $11,278,032 | -35.8% | 444,017 | +2.6% | 0.01% | -38.5% |
| Q4 2022 | $17,560,737 | +24.1% | 432,957 | +1.1% | 0.01% | +18.2% |
| Q3 2022 | $14,153,000 | -7.2% | 428,218 | -1.2% | 0.01% | 0.0% |
| Q2 2022 | $15,259,000 | -12.5% | 433,385 | +14.3% | 0.01% | 0.0% |
| Q1 2022 | $17,434,000 | -38.5% | 379,075 | -11.4% | 0.01% | -35.3% |
| Q4 2021 | $28,371,000 | +2.6% | 427,908 | -3.4% | 0.02% | -5.6% |
| Q3 2021 | $27,645,000 | -35.5% | 442,815 | -14.4% | 0.02% | -35.7% |
| Q2 2021 | $42,832,000 | +24.7% | 517,167 | -0.1% | 0.03% | +16.7% |
| Q1 2021 | $34,337,000 | +29.8% | 517,820 | +50.2% | 0.02% | +20.0% |
| Q4 2020 | $26,452,000 | +85.2% | 344,738 | +3.9% | 0.02% | +66.7% |
| Q3 2020 | $14,286,000 | -3.3% | 331,790 | -3.0% | 0.01% | -7.7% |
| Q2 2020 | $14,767,000 | +34.1% | 341,918 | -10.7% | 0.01% | +8.3% |
| Q1 2020 | $11,015,000 | -65.9% | 382,870 | -24.9% | 0.01% | -55.6% |
| Q4 2019 | $32,329,000 | +39.2% | 509,670 | -38.2% | 0.03% | +35.0% |
| Q3 2019 | $23,223,000 | +6.1% | 824,095 | -0.2% | 0.02% | 0.0% |
| Q2 2019 | $21,878,000 | +1991.6% | 825,583 | +1348.3% | 0.02% | +1900.0% |
| Q1 2019 | $1,046,000 | +50.7% | 57,005 | +2.0% | 0.00% | 0.0% |
| Q4 2018 | $694,000 | -40.3% | 55,911 | -7.9% | 0.00% | 0.0% |
| Q3 2018 | $1,163,000 | +52.8% | 60,680 | +8.5% | 0.00% | 0.0% |
| Q2 2018 | $761,000 | +3208.7% | 55,933 | +355.5% | 0.00% | – |
| Q1 2017 | $23,000 | +43.8% | 12,280 | +15.5% | 0.00% | – |
| Q4 2016 | $16,000 | -79.5% | 10,631 | 0.0% | 0.00% | – |
| Q3 2016 | $78,000 | +36.8% | 10,631 | 0.0% | 0.00% | – |
| Q2 2016 | $57,000 | – | 10,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |